Bio-Rad Labs (BIO) Misses Q3 EPS by 46c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $297.58 +0.50%
EPS Growth %: -30.7%
Financial Fact:
Gross profit: 280.23M
Today's EPS Names:
CCEL, MHGU, PLG, More
EPS Growth %: -30.7%
Financial Fact:
Gross profit: 280.23M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q3 EPS of $0.40, $0.46 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $530.6 million versus the consensus estimate of $525.4 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Disney initiated at Buy as analyst sees parks, streaming fueling next growth phase
- Macquarie cuts Macau gaming sector forecasts on weak GGR growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
